Literature DB >> 25045791

Utility of early postoperative high-resolution volumetric magnetic resonance imaging after transsphenoidal pituitary tumor surgery.

Kunal S Patel1, Jacob Kazam2, Apostolos J Tsiouris2, Vijay K Anand3, Theodore H Schwartz4.   

Abstract

OBJECTIVE: Controversy exists over the utility of early postoperative magnetic resonance imaging (MRI) after transsphenoidal pituitary surgery for macroadenomas. We investigate whether valuable information can be derived from current greater resolution scans.
METHODS: Volumetric MRI scans were obtained in the early (<10 days) and late (>30 days) postoperative periods in a series of patients undergoing transsphenoidal pituitary surgery. The volume of the residual tumor, resection cavity, and corresponding visual field tests were recorded at each time point. Statistical analyses of changes in tumor volume and cavity size were calculated using the late MRI as the gold standard.
RESULTS: A total of 40 patients met the inclusion criteria. Preoperative tumor volume averaged 8.8 cm(3). Early postoperative assessment of average residual tumor volume (1.18 cm(3)) was quite accurate and did not differ statistically from late postoperative volume (1.23 cm(3), P = 0.64), indicating the utility of early scans to measure residual tumor. Early scans were 100% sensitive and 91% specific for predicting ≥ 98% resection (P < 0.001, Fisher exact test). The average percent decrease in cavity volume from preoperative MRI (tumor volume) to early postoperative imaging was 45% with decreases in all but 3 patients. There was no correlation between the size of the early cavity and the visual outcome.
CONCLUSIONS: Early, high-resolution volumetric MRI is valuable in determining the presence or absence of residual tumor. Cavity volume almost always decreases after surgery, and a lack of decrease should alert the surgeon to possible persistent compression of the optic apparatus that may warrant reoperation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pituitary adenoma; Transsphenoidal; Volumetric MRI

Mesh:

Year:  2014        PMID: 25045791      PMCID: PMC4258143          DOI: 10.1016/j.wneu.2014.07.014

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  16 in total

1.  Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.

Authors:  P Kremer; M Forsting; G Ranaei; C Wüster; J Hamer; K Sartor; S Kunze
Journal:  Acta Neurochir (Wien)       Date:  2002-05       Impact factor: 2.216

2.  Pituitary adenomas: findings of postoperative MR imaging.

Authors:  E Steiner; E Knosp; C J Herold; J Kramer; R Stiglbauer; K Staniszewski; H Imhof
Journal:  Radiology       Date:  1992-11       Impact factor: 11.105

3.  MR imaging of pituitary tumors before and after surgical and/or medical treatment.

Authors:  M A Mikhael; I S Ciric
Journal:  J Comput Assist Tomogr       Date:  1988 May-Jun       Impact factor: 1.826

4.  Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery.

Authors:  R J Bohinski; R E Warnick; M F Gaskill-Shipley; M Zuccarello; H R van Loveren; D W Kormos; J M Tew
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

5.  Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors.

Authors:  Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

6.  MR of the pituitary gland postsurgery: serial MR studies following transsphenoidal resection.

Authors:  T S Dina; S H Feaster; E R Laws; D O Davis
Journal:  AJNR Am J Neuroradiol       Date:  1993 May-Jun       Impact factor: 3.825

7.  Determining optimal MRI follow-up after transsphenoidal surgery for pituitary adenoma: scan at 24 hours postsurgery provides reliable information.

Authors:  T Kiliç; G Ekinci; A Seker; I Elmaci; C Erzen; M N Pamir
Journal:  Acta Neurochir (Wien)       Date:  2001-11       Impact factor: 2.216

8.  Postoperative follow-up of pituitary adenomas after trans-sphenoidal resection: MRI and clinical correlation.

Authors:  O Rodríguez; B Mateos; R de la Pedraja; R Villoria; J I Hernando; A Pastor; I Pomposo; J Aurrecoechea
Journal:  Neuroradiology       Date:  1996-11       Impact factor: 2.804

9.  The value of immediate postoperative MR imaging following endoscopic endonasal pituitary surgery.

Authors:  Douglas L Stofko; Thomas Nickles; Haiyan Sun; Amir R Dehdashti
Journal:  Acta Neurochir (Wien)       Date:  2013-08-28       Impact factor: 2.216

10.  Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging.

Authors:  Theodore H Schwartz; Phillip E Stieg; Vijay K Anand
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

View more
  3 in total

1.  Three-dimensional volumetric measurements in defining endoscope-guided giant adenoma surgery outcomes.

Authors:  Muhammad Omar Chohan; Ariana M Levin; Ranjodh Singh; Zhiping Zhou; Carlos L Green; Jacob J Kazam; Apostolos J Tsiouris; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

2.  What is the current clinical practice in pituitary adenoma surgery in Europe? European Pituitary Adenoma Surgery Survey (EU-PASS) results-technical part.

Authors:  Martin Májovský; Andre Grotenhuis; Nicolas Foroglou; Francesco Zenga; Sebastien Froehlich; Florian Ringel; Nicolas Sampron; Nick Thomas; Martin Komarc; David Netuka
Journal:  Neurosurg Rev       Date:  2021-08-02       Impact factor: 2.800

Review 3.  Pituitary adenoma apoplexy caused by rupture of an anterior communicating artery aneurysm: case report and literature review.

Authors:  Kan Xu; Yongjie Yuan; Jing Zhou; Jinlu Yu
Journal:  World J Surg Oncol       Date:  2015-07-30       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.